Subthreshold Depression: Symptoms Below a Diagnostic Threshold
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
Subthreshold depression refers to depressive symptoms that fall below the criteria for a major depressive episode or major depressive disorder (MDD) under a particular diagnostic definition. These symptoms may still cause substantial distress, loss of enjoyment, impaired concentration, fatigue, social withdrawal, or difficulty functioning. The expression is widely used in research and clinical practice, although studies differ in how they define the threshold. The National Institute for Health and Care Excellence (NICE) groups subthreshold symptoms and mild depression under its treatment category of less severe depression while distinguishing the two.
The practical question is how symptoms affect a person's life and what type of support will help. Full diagnostic thresholds organize psychiatric classification, but appropriate assessment considers severity, duration, risk, history, and functioning alongside symptom count. The National Institute of Mental Health (NIMH) states that people with only a few depressive symptoms may benefit from treatment.
I. Definition and Clinical Status
Subthreshold means below a specified threshold. In depression, the term generally describes a clinically relevant pattern of mood-related symptoms that does not meet all the formal requirements for a major depressive episode. Closely related language includes subclinical depression, subsyndromal depression, minor depression, and subthreshold depressive symptoms. Researchers sometimes use these labels with differing symptom-count rules, minimum durations, screening thresholds, or impairment requirements.
There is no single universally agreed operational definition covering every use of subthreshold depression. It is a descriptive clinical and research concept, not one uniform independent diagnosis across DSM-5-TR and ICD-11. An appropriate established diagnosis may be considered after clinical evaluation, including a specified or unspecified depressive disorder when its requirements apply. A symptom description, however, should never be transformed automatically into a diagnosis.
A person can fall below a full-episode threshold in several ways: having fewer qualifying symptoms; an insufficient duration; a pattern that is too intermittent; uncertain clinical significance; or questionnaire results below a selected screening cutoff. These situations are clinically different. A single difficult week after a major disruption and a long-standing pattern of decreased pleasure, poor sleep, and declining functioning can both be described as below threshold, but they require different judgments about monitoring and care.
1. Subthreshold depression versus mild major depression
A person with mild MDD meets the relevant diagnostic criteria for the disorder and has a comparatively less severe symptom burden or functional impact. Subthreshold depression means that those full criteria have not been established. NICE treats both within its broader less-severe-depression care pathway, where clinical need and patient preferences guide decisions. This is a treatment-planning grouping, not a claim that the two labels mean the same thing. NICE NG222.
2. Subthreshold depression versus a screening score
A screening questionnaire can indicate the intensity of symptoms over a certain period and facilitate follow-up. It cannot by itself establish whether every diagnostic criterion is met, whether a medical condition or medication is responsible, whether previous mania has occurred, or what the safest treatment is. The PHQ-9 and other tools are useful components of assessment, not self-diagnostic tests. NICE's use of a PHQ-9 boundary to discuss less versus more severe depression is a guideline framework rather than an individual diagnostic rule.
II. Symptoms and Everyday Presentation
The symptoms associated with subthreshold depression overlap with those considered in clinical depression: persistently reduced mood, loss of interest or pleasure, fatigue, sleep disturbance, appetite changes, difficulty concentrating, low self-esteem, hopelessness, agitation or slowing, and withdrawal from activities. Irritability may be especially prominent among younger people. Their frequency, intensity, duration, context, and combined effects determine clinical significance. NIMH depression overview.
1. Emotional symptoms
Some people feel sad, tearful, or discouraged. Others primarily notice that familiar experiences are emotionally muted: pleasant events offer less reward, social meetings feel effortful, or future plans no longer generate anticipation. A person may seem outwardly competent while privately experiencing a significant decrease in satisfaction and vitality. Visible productivity is an imperfect measure of psychological health.
2. Cognitive and motivational symptoms
Concentration may become inconsistent, decisions harder, and minor problems more overwhelming. Self-criticism can intensify. People may postpone previously manageable activities, reduce contact with friends, or interpret ordinary setbacks as confirmation of personal inadequacy. Reduced activity can in turn limit experiences that support motivation and connection. These are plausible behavioral maintaining processes, not a universal mechanism or a definitive test for depression.
3. Sleep, energy, and bodily changes
Changes in sleep timing or quality, exhaustion, appetite disturbances, restlessness, and physical discomfort may accompany depressive symptoms. Similar complaints occur with chronic pain, sleep disorders, medical disease, medication adverse effects, and substance use. Symptom interpretation therefore requires attention to physical health and the person's normal baseline. NIMH recommends evaluation of medical and medication-related explanations for depressive symptoms.
4. Thoughts about death and suicide
Suicidal ideation or self-harm concerns can occur at different levels of depressive symptom burden, including below an MDD threshold. Diagnostic symptom count never determines whether someone is safe. Ask directly and seek urgent professional help when suicidal thoughts are present. In the United States, people can call or text 988 for crisis support; immediate danger calls for 911 or local emergency services. NIMH crisis information.
III. Differences From Nearby Diagnoses and Terms
1. Sadness and responses to stressful experiences
Sadness is an ordinary human emotional response, particularly after loss, disappointment, conflict, or uncertainty. A clinical discussion becomes important when symptoms endure, recur, cause significant distress, reduce functioning, or create safety concerns. Context matters; even a painful response to circumstances can warrant meaningful support without requiring a categorical depressive diagnosis.
2. Major depressive episode and major depressive disorder
A major depressive episode is defined by a constellation of symptoms over a sufficient period, commonly at least two weeks, with depressed mood or loss of interest as a central feature, clinically significant impact, and relevant exclusions. MDD is a diagnostic formulation that considers the episode and the person's clinical history. Subthreshold depressive symptoms remain below the applicable full-episode criteria. Moving from subthreshold symptoms to MDD can happen but is not inevitable. NIMH.
3. Persistent depressive disorder or dysthymia
Persistent depressive disorder is a recognized diagnosis involving a chronic depressive mood pattern and additional criteria, generally lasting at least two years in adults. Its diagnostic definition is not simply 'subthreshold depression that lasted a long time.' Duration, symptoms, course, and exclusions must be evaluated together. A person with years of persistent low mood should be assessed for this possibility rather than automatically categorized as having only subthreshold symptoms. NIMH.
4. Residual depressive symptoms and partial remission
Residual symptoms occur when some depressive symptoms persist after a previously established episode has improved. Partial remission and recovery concern the course of a known disorder. Initial subthreshold symptoms can appear similar at one appointment, yet their clinical history differs. Previous episodes, response to treatment, residual symptoms, and recurrence risk influence follow-up and prevention planning.
5. High-functioning depression and smiling depression
These expressions are popular descriptive labels, not distinct DSM-5-TR or ICD-11 diagnoses. They may express the discrepancy between externally preserved responsibilities and private distress. Their popularity must not substitute for assessment. Neither apparent cheerfulness nor steady attendance at work proves that symptoms, impairment, or suicide risk are absent. Related historical distinctions are covered in Neurosis vs Depression: Historical Language and Modern Diagnosis.
6. Bipolar depression and activated states
History of hypomania, mania, or mixed mood symptoms requires careful investigation even when a person seeks care for low mood. Periods of increased energy, reduced need for sleep, expansive or markedly irritable mood, accelerated speech, impulsive decisions, or pronounced activation may change the diagnosis and medication risk discussion. Unrecognized bipolar illness cannot be safely managed by assuming every low-mood presentation is unipolar subthreshold depression.
IV. Prevalence and Why Estimates Differ
Subthreshold symptom patterns are reported in primary care, community surveys, workplaces, educational settings, and older-adult populations. Exact prevalence estimates vary greatly with the diagnostic definition, sampling frame, observation period, screening instrument, age, and requirement for distress or functional impairment. One study's percentage should not be presented as a single global rate of a standardized disorder.
A systematic review of adolescent studies concluded that subthreshold depressive presentations were associated with impaired quality of life and elevated risk of subsequent major depressive episodes. It also documented substantial differences in how the condition was defined. This methodological heterogeneity matters whenever a reader encounters apparently conflicting prevalence figures. Bertha and Balázs (2013).
V. Why Symptoms Below a Diagnostic Threshold Matter
Clinical importance cannot be reduced to a binary boundary. Depressive symptoms that fall short of full MDD criteria may still interfere with school, employment, parenting, friendships, physical health management, or the capacity to enjoy ordinary activities. Function may deteriorate gradually. Distress may be intense even when public responsibilities remain intact.
Subthreshold depression is also associated with an increased probability of later major depressive disorder in some longitudinal populations. This describes a group-level relationship, not an individual's destiny. Many people will not develop a major depressive episode. Prevention research investigates whether timely, proportionate intervention can relieve current symptoms and reduce future episodes. Adolescent evidence review; adult prevention meta-analysis00316-X).
Functional assessment asks what the person used to do, what has become harder, and where effort or avoidance has increased. Important domains include sleep, personal care, relationships, attendance, decision-making, enjoyment, and daily routines. Preserved functioning can support less intensive care if symptoms are improving, but the same individual may require closer monitoring when hopelessness, risk, or impairment becomes substantial.
VI. Risk Factors and Possible Maintaining Processes
Relevant vulnerabilities can include previous depressive episodes, family history, prolonged stress, social isolation, conflict, chronic disease, persistent pain, disturbed sleep, anxiety, adverse experiences, and limited access to social or material support. These factors are not interchangeable with causes. The presence of one risk factor never proves that a particular individual will develop depression.
Behavioral and psychological processes can contribute to persistence. Loss of rewarding activity may reduce motivation, while avoidance and rumination may narrow opportunities for corrective experience. Self-critical interpretations may intensify distress. Interventions such as behavioral activation and cognitive behavioral approaches address some of these processes by supporting realistic activity, flexible thinking, and problem solving.
Social context also deserves explicit attention. Care responsibilities, unstable housing, financial stress, discrimination, relationship difficulties, and insufficient rest can influence symptoms and access to care. A meaningful formulation looks at circumstances alongside thoughts, feelings, behavior, and health.
Neurobiological research on reward, stress regulation, sleep, inflammation, and neural systems continues to inform depression science. It does not provide a validated clinical biomarker that individually diagnoses subthreshold depression. Claims that this state proves a single neurotransmitter deficiency or a specific brain lesion go beyond established evidence.
VII. Assessment: What a Clinician Needs to Know
The clinical interview examines what symptoms occur, how often, how long they have lasted, whether they are changing, and how they affect life. A clinician also asks about prior episodes, treatment responses, social support, substances, medications, medical conditions, bipolar-spectrum symptoms, and current safety. The objective is an accurate formulation rather than assigning a label from a checklist. For the complete diagnostic pathway, read Depression Diagnosis: What a Clinical Evaluation Includes.
1. Symptom duration and severity
A brief period of reduced enjoyment after illness or sleep deprivation differs from a sustained pattern with progressive impairment. Similarly, mild subjective distress without significant loss of functioning differs from symptoms that disrupt caregiving or lead to persistent hopelessness. Frequency, duration, clustering, and functional consequences all matter.
2. The role and limits of the PHQ-9
The PHQ-9 can help organize discussion and monitor change. It cannot independently diagnose MDD, persistent depressive disorder, bipolar disorder, or a particular form of subthreshold depression. A total score should be interpreted alongside the clinical interview and any affirmative indication of suicidal thinking. A person's need for support can exceed what a threshold-based interpretation suggests. NICE NG222.
3. Medical and substance-related differential diagnosis
Thyroid disease, anemia, sleep apnea, chronic pain, neurological conditions, substance effects, and adverse reactions to medicines may contribute to fatigue, sleep disturbance, or reduced concentration. Tests are selected according to the person's history and examination. No single blood test confirms subthreshold depression. NIMH.
4. Other mental-health explanations
Anxiety disorders can overlap with depressive symptoms, while adjustment difficulties, trauma-related conditions, grief, burnout, neurodevelopmental differences, and chronic sleep restriction can complicate interpretation. Clinicians assess co-occurring problems and avoid assigning one label merely because it is familiar. Bipolar history, psychotic experiences, and suicidal risk require particular attention because they can change the urgency and type of treatment. For a focused discussion of their overlap, see Anxiety and Depression: Why They Commonly Co-Occur.
VIII. Evidence-Based Care and Appropriate First Steps
The appropriate level of intervention is individualized. Depending on symptoms and circumstances, options may include structured monitoring, guided self-help, brief psychological treatment, behavioral activation, problem-solving approaches, lifestyle and social support, or referral for a more comprehensive evaluation. NICE NG222 recommends shared decision-making for less severe depression and consideration of the least intrusive suitable option.
1. Active monitoring
When symptoms are improving or someone chooses not to start formal treatment, active monitoring includes explaining possible courses, discussing contributing pressures, identifying warning signs, agreeing on practical supports, and arranging reassessment. NICE recommends a review usually within two to four weeks in its less-severe-depression pathway. Follow-up converts observation into a defined care plan. NICE.
2. Guided self-help and low-intensity psychological support
Guided self-help can combine evidence-based material with support from an appropriately trained practitioner. Its content may emphasize activity planning, recognizing negative thought patterns, problem solving, and managing avoidance. The structure, support available, suitability for the person's difficulties, and the option to step up care all influence usefulness.
3. Cognitive behavioral therapy and behavioral activation
Psychological interventions are among the best-studied approaches for subthreshold depressive symptoms. Behavioral activation helps people re-engage gradually with manageable activities that have personal meaning. Cognitive behavioral approaches address patterns of thinking and action that sustain distress. A 2025 systematic review covering 23 randomized trials reported improvements in depressive symptoms and some evidence of reduced progression, although study heterogeneity and limitations in measurement and generalizability remain important. 2025 CBT meta-analysis.
A systematic review of nonpharmacological interventions likewise found favorable effects on depressive symptoms, while a network meta-analysis suggested that psychotherapies, including CBT, compared well with other tested approaches. Rankings of treatment classes from heterogeneous studies are not a guarantee of the best choice for every individual. Huang et al.; He et al..
4. Sleep, activity, social connection, and practical circumstances
Gradually restoring predictable sleep opportunities, realistic physical activity, regular contact with supportive people, and manageable daily goals can complement more structured interventions. These measures should be adapted to disability, medical conditions, work demands, and personal capacity. When environmental pressures are central, practical assistance and changes to circumstances may be essential components of care.
5. Online psychological programs
Structured interventions can be delivered remotely or through digital programs, but results from a studied intervention do not validate every mental-health app or general-purpose AI chatbot. Evidence needs to match the specific intervention, indication, population, and level of clinical support. Privacy, crisis escalation, accessibility, and opportunities to receive human care are especially important.
6. Are antidepressants appropriate?
Medication is not routinely necessary for symptoms below the MDD threshold. NICE advises against routinely offering antidepressants as first-line treatment for less severe depression, including subthreshold depressive symptoms, unless they represent the person's informed preference. The recommendation must be applied to a person's actual diagnosis, prior episodes, comorbidity, and clinical context rather than copied as an absolute rule. NICE NG222.
If medication is under consideration, a prescriber should assess anticipated benefits, adverse effects, interactions, previous response, bipolar history, and safety. People who already take antidepressants should consult their prescriber before reducing or discontinuing treatment; withdrawal symptoms can occur and may need gradual tapering and follow-up. New symptoms during dose reduction require assessment to distinguish withdrawal, relapse, and other causes. NICE antidepressant guidance.
7. Intensive or specialist interventions
Electroconvulsive therapy, transcranial magnetic stimulation, ketamine, and esketamine require condition-specific assessment, appropriate indications, medical oversight, and informed consent. They are not routine interventions for uncomplicated subthreshold depressive symptoms. If psychosis, severe deterioration, significant suicide risk, or another complex mood disorder is present, the clinical formulation and urgency of care change.
IX. Can Early Psychological Treatment Prevent Major Depression?
Indicated prevention means offering an intervention to people who have elevated depressive symptoms without meeting MDD criteria at baseline. Its outcomes may include short-term symptom relief, improvement in daily life, and prevention of a later diagnosed episode. A rigorous prevention study distinguishes baseline diagnosis from screening score and measures subsequent onset with a suitable assessment.
A 2024 individual participant data meta-analysis published in The Lancet Psychiatry synthesized 30 randomized controlled trials involving 7,201 adults with subthreshold symptoms but without MDD at baseline according to standardized diagnostic interviews. Psychological interventions were associated with reduced MDD incidence through 12 months: incidence rate ratio 0.67, 95% confidence interval 0.51–0.88. A clear effect at 24 months was not established from the smaller long-term evidence base. These results support prevention while preserving uncertainty about durability and individual outcomes. Buntrock et al. (2024)00316-X).
A separate individual participant data meta-analysis, published online in 2025 and appearing in a 2026 journal issue, included 50 studies with 10,671 participants. Psychological interventions reduced symptom severity over follow-up periods extending to 12 months, with standardized mean differences of roughly −0.48 to −0.27. Benefits at 24 months were less certain. Initial depression and anxiety severity emerged as credible moderators. Harrer et al..
These findings concern average effects in study populations. A relative reduction in episode incidence does not reveal any one person's absolute risk or guarantee prevention. Outcomes depend on who was enrolled, how the symptoms were defined, what treatment was offered, and how long participants were followed.
An earlier synthesis of seven randomized trials found significant short-term improvement in symptoms after psychological treatment, whereas its estimate of prevention of later MDD was statistically inconclusive. The larger, more recent analyses materially expand the evidence while illustrating why long-term follow-up and precise diagnostic definitions matter. Cuijpers et al..
X. Children and Adolescents
Children and adolescents can experience clinically important depressive symptoms below the full diagnostic threshold. Irritability, declining engagement, reduced enjoyment, changes in sleep, and school or relationship difficulties may warrant attention. Developmental stage, family environment, bullying, trauma exposure, co-occurring anxiety, and safety should be assessed together.
A meta-analytic review of 12 trials involving 1,576 children and adolescents found a modest positive effect of psychological treatments at post-treatment, mainly supported by adolescent data. Effects among children younger than 12 were uncertain, and a statistically reliable preventive effect on subsequent MDD was not demonstrated. Adult prevention findings should not be generalized directly to younger children. Child and adolescent meta-analysis.
Age-appropriate professional evaluation can involve caregivers, school supports, and the young person's preferences while respecting privacy and safety. Severe functional deterioration, self-harm concerns, psychotic experiences, or signs of mania call for prompt assessment irrespective of a questionnaire total.
XI. Older Adults, Chronic Illness, and Social Context
Older adults may experience overlapping depressive symptoms, pain, isolation, sleep disturbances, cognitive complaints, bereavement, mobility restrictions, and medication burden. Depression should not be dismissed as normal aging. Neither should every memory or fatigue complaint be attributed to a psychiatric cause. Medical and psychosocial assessment may require coordinated care.
Chronic physical illness adds a similar interpretive challenge. Fatigue, appetite changes, reduced activity, and sleep disruption may result from disease, its treatment, depressed mood, or several interacting influences. Changes from the person's usual functioning, their emotional experience, and treatment history help clarify next steps.
Social support, caregiving demands, socioeconomic uncertainty, cultural context, and available care influence both the burden of symptoms and the feasibility of intervention. A treatment plan should be realistic for the person's environment rather than demanding changes that available resources make impossible.
XII. When to Seek Care and How to Prepare
Seek a professional assessment when low mood, anhedonia, or related symptoms persist, recur, intensify, or significantly affect responsibilities, relationships, self-care, or enjoyment. Help is appropriate before a formal major-depression diagnosis is established. A primary-care clinician or licensed mental-health professional can evaluate physical health and mental-health explanations and discuss appropriate support. NIMH.
Before an appointment, it can help to note when symptoms began, which activities have become harder, changes in sleep or appetite, substances or medications taken, stressful events, previous depressive episodes, and what has improved or worsened symptoms. Ask what follow-up schedule is sensible and what changes would justify returning sooner.
Seek urgent evaluation for rapidly deteriorating functioning, severe inability to eat or sleep, possible hallucinations or delusions, unusually energized or manic symptoms, or suicidal thinking. For immediate danger, use emergency services. In the United States, the 988 Suicide & Crisis Lifeline is available by call or text. Other countries have their own emergency and crisis pathways. NIMH.
Supporters can help by asking about changes without announcing a diagnosis, listening respectfully, offering assistance with appointments or practical tasks, and taking concerning statements seriously. A person's apparent ability to work or attend school is no substitute for asking how they are doing.
XIII. Prognosis, Follow-Up, and Diagnostic Change
Subthreshold symptoms may improve, fluctuate, persist, recur, or develop into a full major depressive episode. Monitoring examines symptoms, quality of life, safety, and functioning across time. A questionnaire can help describe changes, but it should be interpreted alongside what matters to the person: restored enjoyment, improved concentration, more stable routines, or easier social contact.
If an initial low-intensity intervention does not help, the next step is reassessment. Clinicians may reconsider diagnosis, adequacy of the intervention, chronic stress, medical contributors, access barriers, anxiety, trauma, and bipolar history. Persistent symptoms may warrant a different treatment intensity or referral.
The terms remission, residual symptoms, relapse, and recurrence refer to the course of an established depressive condition and should not be collapsed into the broad category of subthreshold depression. Similarly, treatment-resistant depression requires careful assessment of an established disorder and adequate prior treatments. Difficulty benefiting from casual self-help alone does not establish treatment resistance.
XIV. Frequently Asked Questions
1. Is subthreshold depression a real clinical problem?
Yes. It is a clinically meaningful symptom presentation and a research category, with variable operational definitions. It is not one universally standardized independent psychiatric diagnosis. Distress and impairment can warrant care regardless of whether full MDD criteria are met.
2. Can someone have depression with a low PHQ-9 score?
A low screening score does not exclude meaningful depressive symptoms or override serious impairment or risk. Diagnosis requires clinical evaluation, and questionnaire thresholds serve particular screening or treatment-planning purposes.
3. Is subthreshold depression the same as minor depression?
The labels sometimes overlap but are defined differently across research and classification contexts. Minor depression has been used with particular symptom and duration requirements, while subthreshold depression can refer to a broader range of below-threshold presentations.
4. Is it the same as mild depression?
Mild major depression meets criteria for a depressive disorder or episode while having relatively lower severity. Subthreshold depression does not meet the relevant full-episode threshold. Both may be addressed within a less-severe-depression care pathway.
5. Can it turn into major depressive disorder?
It can, but many people do not progress. Longitudinal research identifies increased group-level risk, and preventive psychological interventions have reduced incidence over several follow-up windows in adult trials. Buntrock et al.00316-X).
6. How long can symptoms last?
There is no single duration inherent in the term. Symptoms can be transient, episodic, or persistent. Long-standing patterns require reassessment for persistent depressive disorder, other conditions, and the need for continuing support.
7. Can CBT help when symptoms are below threshold?
Yes. Meta-analyses of randomized trials find benefits for depressive symptoms in adults, although effect magnitude and duration vary. Choice of intervention should match functional needs, preference, and the evidence for a particular approach. Harrer et al..
8. Do I need an antidepressant?
Not automatically. NICE advises against routine first-line antidepressant use for less severe depression unless it is the person's informed choice. Prior episodes, comorbid disorders, medication history, and clinical risk can affect the decision. NICE NG222.
9. Can someone be suicidal without major depression?
Yes. Suicidal thinking can occur across different diagnostic categories and symptom levels. It calls for direct safety assessment. An apparently low symptom burden should never be used to dismiss risk.
10. What if I still work and appear cheerful?
Outward functioning and appearance do not establish the absence of depressive symptoms. 'High-functioning depression' and 'smiling depression' are informal expressions, and a clinical evaluation is based on history, symptoms, impact, and safety.
Conclusion
Subthreshold depression names a pattern of depressive symptoms that falls below a particular threshold for a full major depressive episode or disorder. The distinction is useful for classification, research, early intervention, and monitoring. Meaningful distress can arise below that boundary; progression to major depression is possible but never predetermined. Effective care evaluates the full clinical situation, provides proportionate support, makes space for informed preferences, follows progress, and responds promptly when functioning or safety changes.
Related Articles
References
Bertha, E. A., & Balázs, J. (2013). Subthreshold depression in adolescence: A systematic review. European Child & Adolescent Psychiatry, 22, 589–603. PubMed.
Buntrock, C., et al. (2024). Psychological interventions to prevent the onset of major depression in adults: A systematic review and individual participant data meta-analysis. The Lancet Psychiatry, 11, 990–1001. DOI00316-X).
Chan, et al. (2025). Long-term effect of cognitive behavioral therapy in managing subclinical depression: A systematic review and meta-analysis. Depression and Anxiety. DOI.
Cuijpers, P., et al. (2007). Psychological treatments of subthreshold depression: A meta-analytic review. Acta Psychiatrica Scandinavica. PubMed.
Harrer, M., et al. (2026). Psychological intervention in individuals with subthreshold depression: Individual participant data meta-analysis of treatment effects and moderators. British Journal of Psychiatry, 229, 78–91. DOI.
He, R., et al. (2022). Nonpharmacological interventions for subthreshold depression in adults: A systematic review and network meta-analysis. Psychiatry Research, 317, 114897. PubMed.
Huang, K., et al. (2023). Effects of non-pharmacological interventions on depressive symptoms and risk of major depressive disorder in adults with subthreshold depression: A systematic review and meta-analysis. Psychiatry Research. PubMed.
National Institute for Health and Care Excellence. (2022). Depression in adults: Treatment and management (NG222). Recommendations.
National Institute of Mental Health. (n.d.). Depression. Official publication.
Psychological treatment of subthreshold depression in children and adolescents. (2021). A meta-analytic review. Journal of the American Academy of Child & Adolescent Psychiatry. PubMed.